Lisa Egbuonu-Davis Biography and Net Worth

Director of Phreesia

Lisa is the former Vice President, Medical Innovations for DH Diagnostics, LLC, an affiliate of Danaher Corporation. In this role, she provided medical advice to influence research, partnership and investment strategy across Danaher’s diagnostic platform businesses. She previously served as Interim Chief Medical Officer for certain subsidiaries of Danaher Corporation; Vice President, Global Patient Centered Outcomes and Solutions at Sanofi, Inc.; Co-Founder and Director of ROI Squared, LLC; Managing Director for LED Enterprise, LLC; and Vice President of U.S. Medical Operations at Pfizer, where she led clinical and outcomes research. She has also served in senior advisory roles for Avalere Health and Booz Allen Hamilton. Lisa is currently on the Board of Directors for Omega Healthcare Investors and Avanos Medical, and she also serves on the Johns Hopkins Medicine Board of Trustees and the National Advisory Council for the Johns Hopkins University School of Education.

What is Lisa Egbuonu-Davis' net worth?: The estimated net worth of Lisa Egbuonu-Davis is at least $382.31 thousand as of August 8th, 2025. Dr. Egbuonu-Davis owns 18,654 shares of Phreesia stock worth more than $382,314 as of December 4th. This net worth estimate does not reflect any other assets that Dr. Egbuonu-Davis may own. Learn More about Lisa Egbuonu-Davis' net worth.
How do I contact Lisa Egbuonu-Davis?: The corporate mailing address for Dr. Egbuonu-Davis and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at [email protected]. Learn More on Lisa Egbuonu-Davis' contact information.
Has Lisa Egbuonu-Davis been buying or selling shares of Phreesia?: Lisa Egbuonu-Davis has not been actively trading shares of Phreesia within the last three months. Most recently, Lisa Egbuonu-Davis sold 465 shares of the business's stock in a transaction on Tuesday, July 15th. The shares were sold at an average price of $27.64, for a transaction totalling $12,852.60. Following the completion of the sale, the director now directly owns 21,572 shares of the company's stock, valued at $596,250.08. Learn More on Lisa Egbuonu-Davis' trading history.
Who are Phreesia's active insiders?: Phreesia's insider roster includes Edward Cahill (Director), Lisa Egbuonu-Davis (Director), Balaji Gandhi (CFO), Allison Hoffman (General Counsel), Yvonne Hui (VP, Principal Accounting Officer), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Mark Smith (Director), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.
Are insiders buying or selling shares of Phreesia?: In the last twelve months, insiders at the sold shares 88 times. They sold a total of 384,262 shares worth more than $10,656,070.27. The most recent insider tranaction occured on October, 17th when CFO Balaji Gandhi sold 885 shares worth more than $19,788.60. Insiders at Phreesia own 5.5% of the company. Learn More about insider trades at Phreesia.
Information on this page was last updated on 10/17/2025.

Lisa Egbuonu-Davis Insider Trading History at Phreesia

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/15/2025	Sell	465	$27.64	$12,852.60	21,572
6/26/2025	Sell	2,802	$27.67	$77,531.34	22,037

Lisa Egbuonu-Davis Buying and Selling Activity at Phreesia

Phreesia Company Overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Today's Range

Now: $20.50

$20.27

$20.67

50 Day Range

MA: $22.16

$19.08

$23.88

2 Week Range

Now: $20.50

$18.55

$32.76

Volume

825,679 shs

Average Volume

754,359 shs

Market Capitalization

$1.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.64